Endothelium-dependent hyperpolarization-related relaxations diminish with age in murine saphenous arteries of both sexes

British Journal of Pharmacology

Volumn 169, Issue 7, 2013, Pages 1486-1499

  Chennupati, Ramesh ^a,b   Lamers, Wouter H ^a   Koehler, S Eleonore ^a   De Mey, Jo G R ^b,c,d  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

EDH related responses; KCa2.3; KCa3.1; L NAME

Indexed keywords

1 [(2 CHLOROPHENYL)DIPHENYLMETHYL] 1H PYRAZOLE; 6, 7 DICHLORO 1H INDOLE 2,3 DIONE 3 OXIME; 6,10 DIAZA 3(1,3)8,(1,4) DIBENZENA 1,5(1,4) DIQUINOLINACYCLODECAPHANE; ACETYLCHOLINE; INDOMETACIN; INTERMEDIATE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; N(G) NITROARGININE METHYL ESTER; NAPHTHO[1,2 D]THIAZOL-2 YLAMINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; NS 309; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL STIMULATING AGENT; SKA 31; SMALL CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY; ARTERY ENDOTHELIUM; ARTICLE; CHANNEL GATING; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG POTENTIATION; DRUG SENSITIVITY; DRUG TARGETING; ENDOTHELIUM DEPENDENT HYPERPOLARIZATION; EXPERIMENTAL MOUSE; FEMALE; HYPERPOLARIZATION; MALE; MOUSE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; SAPHENOUS ARTERY; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SMOOTH MUSCLE RELAXATION; STIMULUS RESPONSE; VASODILATATION; VASOMOTOR REFLEX;

EDH-RELATED RESPONSES; KCA2.3; KCA3.1; L-NAME;

ACETYLCHOLINE; AGING; ALKANES; ANIMALS; ARTERIES; FEMALE; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE; NITROPRUSSIDE; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; PYRAZOLES; QUINOLINIUM COMPOUNDS; VASODILATION; VASODILATOR AGENTS;

EID: 84880271033     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12175     Document Type: Article

References (52)

1. Barton M, Cosentino F, Brandes RP, Moreau P, Shaw S, Luscher TF, (1997). Anatomic heterogeneity of vascular aging: role of nitric oxide and endothelin. Hypertension 30: 817-824.
2. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA, (1994). Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368: 850-853.
3. Brahler S, Kaistha A, Schmidt VJ, Wolfle SE, Busch C, Kaistha BP, et al. (2009). Genetic deficit of SK3 and IK1 channels disrupts the endothelium-derived hyperpolarizing factor vasodilator pathway and causes hypertension. Circulation 119: 2323-2332.
4. Busse R, Edwards G, Feletou M, Fleming I, Vanhoutte PM, Weston AH, (2002). EDHF: bringing the concepts together. Trends Pharmacol Sci 23: 374-380.
5. Bussemaker E, Popp R, Fisslthaler B, Larson CM, Fleming I, Busse R, et al. (2003). Aged spontaneously hypertensive rats exhibit a selective loss of EDHF-mediated relaxation in the renal artery. Hypertension 42: 562-568.
6. Campbell WB, Gauthier KM, (2002). What is new in endothelium-derived hyperpolarizing factors? Curr Opin Nephrol Hypertens 11: 177-183.
7. Castelli WP, (1984). Epidemiology of coronary heart disease: the Framingham study. Am J Med 76 (2A): 4-12.
8. Chadha PS, Liu L, Rikard-Bell M, Senadheera S, Howitt L, Bertrand RL, et al. (2011). Endothelium-dependent vasodilation in human mesenteric artery is primarily mediated by myoendothelial gap junctions intermediate conductance calcium-activated K+ channel and nitric oxide. J Pharmacol Exp Ther 336: 701-708.
9. Damkjaer M, Nielsen G, Bodendiek S, Staehr M, Gramsbergen JB, de Wit C, et al. (2012). Pharmacological activation of KCa3.1/KCa2.3 channels produces endothelial hyperpolarization and lowers blood pressure in conscious dogs. Br J Pharmacol 165: 223-234.
10. DeSouza CA, Shapiro LF, Clevenger CM, Dinenno FA, Monahan KD, Tanaka H, et al. (2000). Regular aerobic exercise prevents and restores age-related declines in endothelium-dependent vasodilation in healthy men. Circulation 102: 1351-1357.
11. Drouin A, Thorin-Trescases N, Hamel E, Falck JR, Thorin E, (2007). Endothelial nitric oxide synthase activation leads to dilatory H2O2 production in mouse cerebral arteries. Cardiovasc Res 73: 73-81.
12. Edwards G, Feletou M, Weston AH, (2010). Endothelium-derived hyperpolarising factors and associated pathways: a synopsis. Pflugers Arch 459: 863-879.
13. Egashira K, Inou T, Hirooka Y, Kai H, Sugimachi M, Suzuki S, et al. (1993). Effects of age on endothelium-dependent vasodilation of resistance coronary artery by acetylcholine in humans. Circulation 88: 77-81.
14. Farhat MY, Lavigne MC, Ramwell PW, (1996). The vascular protective effects of estrogen. FASEB J 10: 615-624.
15. Feletou M, Vanhoutte PM, (1999). The third pathway: endothelium-dependent hyperpolarization. J Physiol Pharmacol 50: 525-534.
16. Feletou M, Vanhoutte PM, (2009). EDHF: an update. Clin Sci (Lond) 117: 139-155.
17. Fujii K, Ohmori S, Tominaga M, Abe I, Takata Y, Ohya Y, et al. (1993). Age-related changes in endothelium-dependent hyperpolarization in the rat mesenteric artery. Am J Physiol 265 (2 Pt 2): H509-H516.
18. Fujiki T, Shimokawa H, Morikawa K, Kubota H, Hatanaka M, Talukder MA, et al. (2005). Endothelium-derived hydrogen peroxide accounts for the enhancing effect of an angiotensin-converting enzyme inhibitor on endothelium-derived hyperpolarizing factor-mediated responses in mice. Arterioscler Thromb Vasc Biol 25: 766-771.
19. Goto K, Fujii K, Onaka U, Abe I, Fujishima M, (2000). Renin-angiotensin system blockade improves endothelial dysfunction in hypertension. Hypertension 36: 575-580.
20. Goto K, Kansui Y, Oniki H, Ohtsubo T, Matsumura K, Kitazono T, (2012). Upregulation of endothelium-derived hyperpolarizing factor compensates for the loss of nitric oxide in mesenteric arteries of dahl salt-sensitive hypertensive rats. Hypertens Res 35: 849-854.
21. + channels in normal and impaired EDHF-dilator responses-relevance to cardiovascular pathologies and drug discovery. Br J Pharmacol 157: 509-526.
22. Haddock RE, Grayson TH, Morris MJ, Howitt L, Chadha PS, Sandow SL, (2011). Diet-induced obesity impairs endothelium-derived hyperpolarization via altered potassium channel signaling mechanisms. PLoS ONE 6: e16423.
23. Harrington LS, Carrier MJ, Gallagher N, Gilroy D, Garland CJ, Mitchell JA, (2007). Elucidation of the temporal relationship between endothelial-derived NO and EDHF in mesenteric vessels. Am J Physiol Heart Circ Physiol 293: H1682-H1688.
24. Hasenau AL, Nielsen G, Morisseau C, Hammock BD, Wulff H, Kohler R, (2011). Improvement of endothelium-dependent vasodilations by SKA-31 and SKA-20, activators of small- and intermediate-conductance Ca2+ -activated K+ -channels. Acta Physiol (Oxf) 203: 117-126.
25. Hecker M, (2000). Endothelium-derived hyperpolarizing factor-fact or fiction? News Physiol Sci 15: 1-5.
26. Hilgers RH, Webb RC, (2007). Reduced expression of SKCa and IKCa channel proteins in rat small mesenteric arteries during angiotensin II-induced hypertension. Am J Physiol Heart Circ Physiol 292: H2275-H2284.
27. Hilgers RH, Janssen GM, Fazzi GE, De Mey JG, (2010). Twenty-four-hour exposure to altered blood flow modifies endothelial Ca2+-activated K+ channels in rat mesenteric arteries. J Pharmacol Exp Ther 333: 210-217.
28. Huang A, Sun D, Smith CJ, Connetta JA, Shesely EG, Koller A, et al. (2000). In eNOS knockout mice skeletal muscle arteriolar dilation to acetylcholine is mediated by EDHF. Am J Physiol Heart Circ Physiol 278: H762-H768.
29. Kohler R, Ruth P, (2010). Endothelial dysfunction and blood pressure alterations in K+-channel transgenic mice. Pflugers Arch 459: 969-976.
30. Lesniewski LA, Connell ML, Durrant JR, Folian BJ, Anderson MC, Donato AJ, et al. (2009). B6D2F1 mice are a suitable model of oxidative stress-mediated impaired endothelium-dependent dilation with aging. J Gerontol A Biol Sci Med Sci 64: 9-20.
31. Liu B, Luo W, Zhang Y, Li H, Zhu N, Huang D, et al. (2012). Involvement of cyclo-oxygenase-1-mediated prostacyclin synthesis in the vasoconstrictor activity evoked by ACh in mouse arteries. Exp Physiol 97: 277-289.
32. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al. (2010). Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121: e46-e215.
33. McCulloch AI, Randall MD, (1998). Sex differences in the relative contributions of nitric oxide and EDHF to agonist-stimulated endothelium-dependent relaxations in the rat isolated mesenteric arterial bed. Br J Pharmacol 123: 1700-1706.
34. Orshal JM, Khalil RA, (2004). Gender, sex hormones, and vascular tone. Am J Physiol Regul Integr Comp Physiol 286: R233-R249.
35. Rosa JC, Galanakis D, Ganellin CR, Dunn PM, Jenkinson DH, (1998). Bis-quinolinium cyclophanes: 6,10-diaza-3(1,3),8(1,4)-dibenzena-1,5(1,4)- diquinolinacyclodecaphane (UCL 1684), the first nanomolar, non-peptidic blocker of the apamin-sensitive Ca(2+)-activated K+ channel. J Med Chem 41: 2-5.
36. Sandow SL, Goto K, Rummery NM, Hill CE, (2004). Developmental changes in myoendothelial gap junction mediated vasodilator activity in the rat saphenous artery. J Physiol 556 (Pt 3): 875-886.
37. Sankaranarayanan A, Raman G, Busch C, Schultz T, Zimin PI, Hoyer J, et al. (2009). Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure. Mol Pharmacol 75: 281-295.
38. Scotland RS, Madhani M, Chauhan S, Moncada S, Andresen J, Nilsson H, et al. (2005). Investigation of vascular responses in endothelial nitric oxide synthase/cyclooxygenase-1 double-knockout mice: key role for endothelium-derived hyperpolarizing factor in the regulation of blood pressure in vivo. Circulation 111: 796-803.
39. Senadheera S, Kim Y, Grayson TH, Toemoe S, Kochukov MY, Abramowitz J, et al. (2012). Transient receptor potential canonical type 3 channels facilitate endothelium-derived hyperpolarization-mediated resistance artery vasodilator activity. Cardiovasc Res 95: 439-447.
40. Si H, Heyken WT, Wolfle SE, Tysiac M, Schubert R, Grgic I, et al. (2006). Impaired endothelium-derived hyperpolarizing factor-mediated dilations and increased blood pressure in mice deficient of the intermediate-conductance Ca2+-activated K+ channel. Circ Res 99: 537-544.
41. Strobaek D, Teuber L, Jorgensen TD, Ahring PK, Kjaer K, Hansen RS, et al. (2004). Activation of human IK and SK Ca2+ -activated K+ channels by NS309 (6,7-dichloro-1H-indole-2,3-dione 3-oxime). Biochim Biophys Acta 1665: 1-5.
42. Sunano S, Watanabe H, Tanaka S, Sekiguchi F, Shimamura K, (1999). Endothelium-derived relaxing, contracting and hyperpolarizing factors of mesenteric arteries of hypertensive and normotensive rats. Br J Pharmacol 126: 709-716.
43. Taddei S, Virdis A, Ghiadoni L, Salvetti G, Bernini G, Magagna A, et al. (2001). Age-related reduction of NO availability and oxidative stress in humans. Hypertension 38: 274-279.
44. Taddei S, Versari D, Cipriano A, Ghiadoni L, Galetta F, Franzoni F, et al. (2006). Identification of a cytochrome P450 2C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients. J Am Coll Cardiol 48: 508-515.
45. Takaki A, Morikawa K, Murayama Y, Yamagishi H, Hosoya M, Ohashi J, et al. (2008a). Roles of endothelial oxidases in endothelium-derived hyperpolarizing factor responses in mice. J Cardiovasc Pharmacol 52: 510-517.
46. Takaki A, Morikawa K, Tsutsui M, Murayama Y, Tekes E, Yamagishi H, et al. (2008b). Crucial role of nitric oxide synthases system in endothelium-dependent hyperpolarization in mice. J Exp Med 205: 2053-2063.
47. Taylor MS, Bonev AD, Gross TP, Eckman DM, Brayden JE, Bond CT, et al. (2003). Altered expression of small-conductance Ca2+-activated K+ (SK3) channels modulates arterial tone and blood pressure. Circ Res 93: 124-131.
48. Tschudi MR, Barton M, Bersinger NA, Moreau P, Cosentino F, Noll G, et al. (1996). Effect of age on kinetics of nitric oxide release in rat aorta and pulmonary artery. J Clin Invest 98: 899-905.
49. Wigg SJ, Tare M, Tonta MA, O'Brien RC, Meredith IT, Parkington HC, (2001). Comparison of effects of diabetes mellitus on an EDHF-dependent and an EDHF-independent artery. Am J Physiol Heart Circ Physiol 281: H232-H240.
50. de Wit C, Griffith TM, (2010). Connexins and gap junctions in the EDHF phenomenon and conducted vasomotor responses. Pflugers Arch 459: 897-914.
51. Wulff H, Miller MJ, Hansel W, Grissmer S, Cahalan MD, Chandy KG, (2000). Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressant. Proc Natl Acad Sci U S A 97: 8151-8156.
52. Zhou Y, Varadharaj S, Zhao X, Parinandi N, Flavahan NA, Zweier JL, (2005). Acetylcholine causes endothelium-dependent contraction of mouse arteries. Am J Physiol Heart Circ Physiol 289: H1027-H1032.